PortfoliosLab logo
VRSK vs. DXCM
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between VRSK and DXCM is 0.53, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.5

Performance

VRSK vs. DXCM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Verisk Analytics, Inc. (VRSK) and DexCom, Inc. (DXCM). The values are adjusted to include any dividend payments, if applicable.

1,000.00%2,000.00%3,000.00%4,000.00%5,000.00%December2025FebruaryMarchAprilMay
1,023.82%
4,043.15%
VRSK
DXCM

Key characteristics

Sharpe Ratio

VRSK:

1.63

DXCM:

-0.62

Sortino Ratio

VRSK:

2.14

DXCM:

-0.50

Omega Ratio

VRSK:

1.34

DXCM:

0.91

Calmar Ratio

VRSK:

3.87

DXCM:

-0.57

Martin Ratio

VRSK:

8.23

DXCM:

-0.93

Ulcer Index

VRSK:

4.33%

DXCM:

38.58%

Daily Std Dev

VRSK:

20.80%

DXCM:

58.53%

Max Drawdown

VRSK:

-30.88%

DXCM:

-94.61%

Current Drawdown

VRSK:

-3.67%

DXCM:

-49.87%

Fundamentals

Market Cap

VRSK:

$41.13B

DXCM:

$32.00B

EPS

VRSK:

$6.67

DXCM:

$1.33

PE Ratio

VRSK:

44.06

DXCM:

61.37

PEG Ratio

VRSK:

3.94

DXCM:

1.10

PS Ratio

VRSK:

14.27

DXCM:

6.83

PB Ratio

VRSK:

410.89

DXCM:

13.31

Total Revenue (TTM)

VRSK:

$2.18B

DXCM:

$4.15B

Gross Profit (TTM)

VRSK:

$1.43B

DXCM:

$2.46B

EBITDA (TTM)

VRSK:

$1.18B

DXCM:

$889.80M

Returns By Period

In the year-to-date period, VRSK achieves a 6.87% return, which is significantly higher than DXCM's 4.95% return. Over the past 10 years, VRSK has underperformed DXCM with an annualized return of 15.60%, while DXCM has yielded a comparatively higher 17.13% annualized return.


VRSK

YTD

6.87%

1M

3.13%

6M

7.00%

1Y

24.56%

5Y*

14.06%

10Y*

15.60%

DXCM

YTD

4.95%

1M

36.42%

6M

16.02%

1Y

-36.42%

5Y*

-2.18%

10Y*

17.13%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

VRSK vs. DXCM — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VRSK
The Risk-Adjusted Performance Rank of VRSK is 9292
Overall Rank
The Sharpe Ratio Rank of VRSK is 9292
Sharpe Ratio Rank
The Sortino Ratio Rank of VRSK is 8787
Sortino Ratio Rank
The Omega Ratio Rank of VRSK is 9090
Omega Ratio Rank
The Calmar Ratio Rank of VRSK is 9898
Calmar Ratio Rank
The Martin Ratio Rank of VRSK is 9393
Martin Ratio Rank

DXCM
The Risk-Adjusted Performance Rank of DXCM is 2020
Overall Rank
The Sharpe Ratio Rank of DXCM is 1717
Sharpe Ratio Rank
The Sortino Ratio Rank of DXCM is 2222
Sortino Ratio Rank
The Omega Ratio Rank of DXCM is 1818
Omega Ratio Rank
The Calmar Ratio Rank of DXCM is 1515
Calmar Ratio Rank
The Martin Ratio Rank of DXCM is 2929
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

VRSK vs. DXCM - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Verisk Analytics, Inc. (VRSK) and DexCom, Inc. (DXCM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for VRSK, currently valued at 1.63, compared to the broader market-2.00-1.000.001.002.003.00
VRSK: 1.63
DXCM: -0.62
The chart of Sortino ratio for VRSK, currently valued at 2.14, compared to the broader market-6.00-4.00-2.000.002.004.00
VRSK: 2.14
DXCM: -0.50
The chart of Omega ratio for VRSK, currently valued at 1.34, compared to the broader market0.501.001.502.00
VRSK: 1.34
DXCM: 0.91
The chart of Calmar ratio for VRSK, currently valued at 3.87, compared to the broader market0.001.002.003.004.005.00
VRSK: 3.87
DXCM: -0.57
The chart of Martin ratio for VRSK, currently valued at 8.23, compared to the broader market-10.000.0010.0020.00
VRSK: 8.23
DXCM: -0.93

The current VRSK Sharpe Ratio is 1.63, which is higher than the DXCM Sharpe Ratio of -0.62. The chart below compares the historical Sharpe Ratios of VRSK and DXCM, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.50December2025FebruaryMarchAprilMay
1.63
-0.62
VRSK
DXCM

Dividends

VRSK vs. DXCM - Dividend Comparison

VRSK's dividend yield for the trailing twelve months is around 0.55%, while DXCM has not paid dividends to shareholders.


TTM202420232022202120202019
VRSK
Verisk Analytics, Inc.
0.55%0.57%0.57%0.70%0.51%0.52%0.67%
DXCM
DexCom, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

VRSK vs. DXCM - Drawdown Comparison

The maximum VRSK drawdown since its inception was -30.88%, smaller than the maximum DXCM drawdown of -94.61%. Use the drawdown chart below to compare losses from any high point for VRSK and DXCM. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%December2025FebruaryMarchAprilMay
-3.67%
-49.87%
VRSK
DXCM

Volatility

VRSK vs. DXCM - Volatility Comparison

The current volatility for Verisk Analytics, Inc. (VRSK) is 10.59%, while DexCom, Inc. (DXCM) has a volatility of 22.57%. This indicates that VRSK experiences smaller price fluctuations and is considered to be less risky than DXCM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%December2025FebruaryMarchAprilMay
10.59%
22.57%
VRSK
DXCM

Financials

VRSK vs. DXCM - Financials Comparison

This section allows you to compare key financial metrics between Verisk Analytics, Inc. and DexCom, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


400.00M600.00M800.00M1.00B1.20B20212022202320242025
735.60M
1.04B
(VRSK) Total Revenue
(DXCM) Total Revenue
Values in USD except per share items

VRSK vs. DXCM - Profitability Comparison

The chart below illustrates the profitability comparison between Verisk Analytics, Inc. and DexCom, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

60.0%65.0%70.0%20212022202320242025
68.7%
56.9%
(VRSK) Gross Margin
(DXCM) Gross Margin
VRSK - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Verisk Analytics, Inc. reported a gross profit of 505.10M and revenue of 735.60M. Therefore, the gross margin over that period was 68.7%.
DXCM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, DexCom, Inc. reported a gross profit of 589.00M and revenue of 1.04B. Therefore, the gross margin over that period was 56.9%.
VRSK - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Verisk Analytics, Inc. reported an operating income of 316.30M and revenue of 735.60M, resulting in an operating margin of 43.0%.
DXCM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, DexCom, Inc. reported an operating income of 133.70M and revenue of 1.04B, resulting in an operating margin of 12.9%.
VRSK - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Verisk Analytics, Inc. reported a net income of 210.30M and revenue of 735.60M, resulting in a net margin of 28.6%.
DXCM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, DexCom, Inc. reported a net income of 105.40M and revenue of 1.04B, resulting in a net margin of 10.2%.